Clincosm LogoSign in Get a demo

The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants

Sponsor
The First Hospital of Jilin University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05788562
Collaborator
(none)
92
Enrollment
1
Location
14
Anticipated Duration (Months)
6.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A monocentric prospective study was conducted to find the relevance between the level of fetal hemoglobin and short-term complications in extremely preterm infants

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    92 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants
    Anticipated Study Start Date :
    Apr 1, 2023
    Anticipated Primary Completion Date :
    Feb 18, 2024
    Anticipated Study Completion Date :
    May 30, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Experimental group

    Incorporate blood gas analysis indicators in D1-D7, after birth,1 week before and on the day of onset of early complications
    Control group

    Incorporate blood gas analysis indicators in D1-D7,D14,D28after birth and the day of diacharge

    Outcome Measures

    Primary Outcome Measures

    1. Occurrence and severity of early complications in premature infants [2022.1-2023.1]

      include necrotizing enterocolitis,bronchopulmonary dysplasia,retinopathy, Intraventricular hemorrhage above degree Ⅱ,leukomalacia,late-onset sepsis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 2 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1. Preterm infants with gestational age <32 weeks or birth weight <1500g

    2. Parents agree to attend

    Exclusion Criteria:

    1. serious functional or organic diseases

    2. severe congenital deformity

    3. parents reject to attend

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 First hospital of Jilin University Chang chun Jilin China 130000

    Sponsors and Collaborators

    • The First Hospital of Jilin University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The First Hospital of Jilin University
    ClinicalTrials.gov Identifier:
    NCT05788562
    Other Study ID Numbers:
    • wu hui
    First Posted:
    Mar 29, 2023
    Last Update Posted:
    Mar 29, 2023
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 29, 2023